University of Oklahoma at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

University of Oklahoma brings 4 presentations to ObesityWeek 2026 in National Harbor. Its program centers on lab studies of muscle and liver metabolism, including how removing MIRO1 from muscle protects against liver fibrosis and how liver UCP2 controls energy use. It also reports more than additive weight loss from combining melanocortin receptor agonism with phentermine/topiramate.

OrganizationObesityWeek 2026 Attendance
Universities & research institutes
Public research university in Norman, Oklahoma.
Talk
Sat Nov 14
1:15pm–1:30pm
Poster
Sun Nov 15
2:30pm–3:30pm
Super-Additive Weight Loss From Combining Melanocortin Receptor Agonism With Phentermine/Topiramate
Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice
Poster
Mon Nov 16
2:30pm–3:30pm
Sex-Specific Predictors of Muscle Function in Older Adults With Obesity
Pediatric and adolescent obesityObesity pharmacotherapy and drug development

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Oklahoma

Tell us what you sell and we’ll find the people at University of Oklahoma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction